🇺🇸 FDA
Patent

US 12161672

Chimeric antigen receptor and methods of use thereof

granted A61KA61K2039/505A61K2239/23

Quick answer

US patent 12161672 (Chimeric antigen receptor and methods of use thereof) held by The Regents of the University of California expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2239/23, A61K2239/24, A61K2239/31